CARsgen Therapeutics Holdings (HKSE:02171) Gross-Profit-to-Asset % : 1.38% (As of Dec. 2024)

CARsgen Therapeutics Holdings Gross-Profit-to-Asset % Chart

CARsgen Therapeutics Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial						-	-	-	0.15	1.38

Competitive Comparison of CARsgen Therapeutics Holdings's Gross-Profit-to-Asset %

For the Biotechnology subindustry, CARsgen Therapeutics Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CARsgen Therapeutics Holdings's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CARsgen Therapeutics Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where CARsgen Therapeutics Holdings's Gross-Profit-to-Asset % falls into.

CARsgen Therapeutics Holdings Gross-Profit-to-Asset % Calculation

CARsgen Therapeutics Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

CARsgen Therapeutics Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

CARsgen Therapeutics Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of CARsgen Therapeutics Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

CARsgen Therapeutics Holdings Business Description